D68.4

Acquired coagulation factor deficiency

Acquired coagulation factor deficiency (D68.4) is a clinical condition characterized by a non-congenital reduction in the concentration or functional activity of one or more blood clotting factors. Unlike hereditary coagulopathies like Hemophilia A or B, this condition arises secondary to other pathological processes or external influences. The most common etiology is hepatic disease, as the liver is the primary site for the synthesis of most clotting factors (I, II, V, VII, IX, X, XI, and XII). Another frequent cause is Vitamin K deficiency, which impairs the gamma-carboxylation of factors II, VII, IX, and X, as well as proteins C and S. Acquired deficiency can also result from consumption coagulopathies such as Disseminated Intravascular Coagulation (DIC), where factors are depleted rapidly through systemic microvascular thrombosis, or through the development of acquired inhibitors (autoantibodies). Clinical management necessitates a dual approach: addressing the underlying cause and providing replacement therapy via Fresh Frozen Plasma (FFP), prothrombin complex concentrates (PCCs), or specific factor concentrates during acute hemorrhagic episodes.

Clinical Symptoms

  • Ecchymosis (easy bruising) without significant trauma
  • Petechiae and purpura
  • Prolonged bleeding from minor cuts or abrasions
  • Epistaxis (recurrent or severe nosebleeds)
  • Gingival bleeding (bleeding gums)
  • Hematuria (blood in the urine)
  • Gastrointestinal bleeding (melena or hematochezia)
  • Menorrhagia (abnormally heavy or prolonged menstrual bleeding)
  • Hemarthrosis (bleeding into joint spaces, typically in severe cases)
  • Intramuscular hematomas
  • Excessive post-surgical or post-procedural bleeding
  • Intracranial hemorrhage (in life-threatening instances)

Common Causes

  • Severe liver disease (cirrhosis, fulminant hepatic failure, chronic hepatitis)
  • Vitamin K deficiency (due to dietary insufficiency, malabsorption syndromes, or biliary obstruction)
  • Pharmacological antagonism (Warfarin or other vitamin K antagonists)
  • Disseminated Intravascular Coagulation (DIC)
  • Massive transfusion syndrome (dilutional coagulopathy)
  • Acquired inhibitors/autoantibodies against specific factors (e.g., Acquired Hemophilia A)
  • Nephrotic syndrome (urinary loss of specific factors like Factor IX)
  • Severe malnutrition or protein-losing enteropathy
  • Prolonged broad-spectrum antibiotic therapy (altering gut flora that produce Vitamin K)

Documentation & Coding Tips

Explicitly Document the Underlying Etiology for the Deficiency

Example: Patient presents with acquired coagulation factor deficiency secondary to Child-Pugh Class C cirrhosis. Clinical manifestation includes prolonged PT and PTT with spontaneous ecchymosis. This documentation supports the diagnosis of D68.4 while linking it to the primary liver condition, which is essential for accurate HCC 48 risk adjustment and severity leveling.

Billing Focus: Identify the primary cause such as liver disease or malabsorption to satisfy coding specificity and ensure appropriate sequencing of the primary diagnosis.

Distinguish Between Acquired and Hereditary Coagulation Disorders

Example: Patient has no family history of hemophilia and genetic testing was negative; however, current lab values show a 15 percent Factor VII activity level following extensive bowel resection. This confirms an acquired deficiency D68.4 rather than a congenital defect D66-D68.2. Explicitly stating the deficiency is acquired prevents incorrect coding of hereditary conditions.

Billing Focus: Use specific terminology such as acquired to distinguish from D66-D68.2 codes, which are reserved for congenital deficiencies.

Clarify the Relationship with Anticoagulant Use

Example: Patient on chronic Warfarin therapy presents with non-iatrogenic acquired coagulation factor deficiency. PT/INR is elevated beyond therapeutic targets due to underlying hepatic congestion. Documenting that the deficiency is pathological and not solely a therapeutic effect of the drug allows for the use of D68.4.

Billing Focus: Avoid using D68.4 if the coagulopathy is a normal expected therapeutic outcome of anticoagulant therapy; instead, use D68.32 for hemorrhagic disorders due to extrinsic anticoagulants if applicable.

Document Clinical Manifestations of the Deficiency

Example: Acquired coagulation factor deficiency manifested by persistent epistaxis and intramuscular hematoma of the right thigh. Patient required 2 units of FFP to correct coagulopathy. Documentation of specific bleeding sites provides justification for high-complexity medical decision making (99215).

Billing Focus: Laterality and specific anatomical sites of bleeding must be documented to support secondary diagnosis codes such as R04.0 for epistaxis.

Link Lab Abnormalities to Clinical Diagnosis

Example: Coagulation profile reveals PT 22.4 and PTT 48.2 with low Factor II and X levels, diagnostic of acquired coagulation factor deficiency due to vitamin K malabsorption from Crohn's disease. Simply listing labs is insufficient; the physician must interpret them as D68.4.

Billing Focus: Documentation must translate lab values into a definitive diagnosis to be captured by professional coders.

Relevant CPT Codes

Related Diagnoses

Hierarchy